Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

DARK SECRETS: 2 | Vintage Vibes

Janssen's Tremfya Shows Clinical Response At 12 Weeks In Ulcerative Colitis

Janssen Pharmaceutical, a unit of Johnson & Johnson (NYSE: JNJ), has announced results from the

Benzinga · Feb 18, 2022

AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial

AC Immune SA (NASDAQ: ACIU) and partner Janssen, a unit of Johnson & Johnson (NYSE: JNJ), have found that an early-stage Alzheimer's vaccine spurs induction of antibodies that attack a type of tau, a

Benzinga · Feb 15, 2022

Why Are AstraZeneca Shares Trading Higher Today

Adding AstraZeneca Plc's (NASDAQ: AZN) Lynparza to Johnson & Johnson's (NYSE: JNJ) Zytiga (abiraterone) extended the time to live without disease progression in patients with newly diagnosed

Benzinga · Feb 15, 2022

From analysis to the latest developments in health,
read the most diverse news in one place.

J&J starts trial on bankruptcy case under attack by Congress

The controversial Johnson & Johnson bankruptcy strategy that’s drawn the ire of Congress faces a fresh trial this week, with the consumer products giant arguing that settling billions of dollars of talc liabilities in a single case is better for cancer victims than fighting thousands of individual claims.

Tribune News Service · Feb 14, 2022

Benzinga Bulls And Bears Of The Past Week: Meta, Spotify, Peloton, Twitter, Johnson & Johnson And More

Benzinga has examined the prospects for many investor favorite stocks over the past week.

Benzinga · Feb 12, 2022

US Ships Nearly 1.9 Mn More COVID Vaccine Doses to African Nations

The United States on Friday shipped nearly 1.9 million COVID-19 vaccine doses to Mozambique and four other African countries in the latest surge of donations, a US official told AFP. "Thanks to the US commitment to playing a leading role in ending the pandemic everywhere," Mozambique will receive 840,000 Johnson…

Asharq Al-Awsat · Feb 11, 2022

Final Analysis Show Johnson & Johnson's COVID-19 Offers Only 52.9% Protection

Scientists have revealed data from their final analysis of Johnson & Johnson's (NYSE: JNJ) COVID-19 Phase 3 study, showing the vaccine may be even less effective in the longer term.

Benzinga · Feb 10, 2022

Read news from The Economist, FT, and more,
with one subscription

Johnson & Johnson Halts Production Of Its COVID-19 Vaccine: NYT

Johnson & Johnson (NYSE: JNJ) quietly shut down the only plant making usable batches of its COVID-19 vaccine, the

Benzinga · Feb 8, 2022

J&J may be forced to stop selling talc in UK as cancer court cases continue

"Various studies have shown a link between using talcum powder between the legs and ovarian cancer."

Wales Online · Feb 6, 2022

Johnson & Johnson faces push to force global ban on talc baby powder sales

Move to hold shareholder vote follows withdrawal of product in US and Canada and lawsuits alleging link to cancer cases

The Guardian - UK · Feb 6, 2022

Hopeful Golden Cross Forms On Johnson & Johnson's Chart

If history is any guide, there may be good fortune ahead for shares of Johnson & Johnson (NYSE:JNJ). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga · Feb 3, 2022

Covid rules on travelling to different countries around Europe

Here's everything you need to know about vaccination status and testing process in countries such as France, Austria, Switzerland and Italy

Wales Online · Feb 2, 2022

Johnson & Johnson recipients can get third COVID shot in San Francisco

SAN FRANCISCO — San Francisco health officials are allowing people who originally got the Johnson & Johnson COVID-19 vaccine to get a second booster shot — which would give them access to the same number of doses currently available to recipients of Pfizer-BioNTech or Moderna.

Los Angeles Times · Feb 2, 2022

Johnson & Johnson, Distributors Reach $590M Opioid Settlement For Tribe Claims: Report

Johnson & Johnson (NYSE: JNJ) and the three U.S.

Benzinga · Feb 2, 2022

Get all your
news in one place.

100's of premium titles.
One news app.

Axios · Feb 2, 2022

Native American tribes reach $590M opioid settlement with Johnson & Johnson and distributors

It's the largest opioid settlement for Native Americans.

Benzinga · Jan 31, 2022

Johnson & Johnson Whale Trades Spotted

Someone with a lot of money to spend has taken a bearish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jan 25, 2022

This Is What Whales Are Betting On Johnson & Johnson

Someone with a lot of money to spend has taken a bullish stance on Johnson & Johnson (NYSE:JNJ). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga · Jan 25, 2022

Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views

Following the market opening Tuesday, the Dow traded down 1.79% to 33,748.82 while the NASDAQ fell 2.56% to 13,499.97. The S&P also fell, dropping, 2.59% to 13,496.29.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga · Jan 25, 2022

Johnson & Johnson's FY21 COVID-19 Vaccine Sales Below Expectations

Johnson & Johnson (NYSE: JNJ)

Benzinga · Jan 25, 2022

Johnson & Johnson: Q4 Earnings Insights

Johnson & Johnson (NYSE:JNJ) reported its Q4 earnings results on Tuesday, January 25, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga · Jan 25, 2022

5 Stocks To Watch For January 25, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Johnson & Johnson (NYSE: JNJ) to report quarterly earnings at $2.12 per share on revenue of $25.29 billion before the opening bell. Johnson & Johnson shares fell 0.3% to $162.50 in after-hours trading.

Benzinga · Jan 24, 2022

Johnson & Johnson's Earnings: A Preview

Johnson & Johnson (NYSE:JNJ) is set to give its latest quarterly earnings report on Tuesday, 2022-01-25. Here's what investors need to know before the announcement. Analysts estimate that Johnson & Johnson will likely report an Earnings Per Share (EPS) of $2.12.

Asharq Al-Awsat · Jan 19, 2022

Hajj, Umrah Ministry Exempts Immunized with Approved Vaccines from Quarantine

Saudi Arabia’s Ministry of Hajj and Umrah has decided that travelers inbound to the Kingdom who have received a full dose of one of the approved vaccines, including Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson, Moderna, are exempt from the need to quarantine. In a statement to Asharq Al-Awsat, the Ministry revealed…

1 2

Coverage From

Organisations

Ministry of Hajj and Umrah

18 stories

J&J

15 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Places

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.